Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2608-2611, December 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dick, F. R.
Right arrow Articles by Yunis, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dick, F. R.
Right arrow Articles by Yunis, E. J.

HL-A and Lymphoid Tumors1

Fred R. Dick2, Ignacio Fortuny, Athanasios Theologides, John Greally3, Nancy Wood and Edmond J. Yunis4

Department of Laboratory Medicine [F. R. D., J. G. N. W., E. J. Y.], and the Department of Medicine [I. F., A. T.], University of Minnesota, Health Sciences Center, Minneapolis, Minnesota 55455

The incidence of HL-A antigens on peripheral lymphocytes of 154 patients with lymphoid tumors has been compared with that of 383 controls. With the use of the simple X2 test and a 5% level of significance, seven different associations appear to be valid. However, when the p value is corrected by multiplying it by the number of factors investigated, only the association of HL-A12 with lymphocytic lymphomas and the 4c antigen with chronic lymphatic leukemia appear to be significant. The previously described increased incidence of W5 and 4c in Hodgkin's disease was not found in the population studied, nor was the HL-A2-12 phenotype found to be increased in acute lymphatic leukemia.

1 This work was supported in part by American Cancer Society Institutional Research Grant IN-13L, Cardiovascular Program Project Grant HE-06314; National Cancer Institute Grants CA 08101, CA 05158, and CA 08832; and the Edmond J. Yunis Fund, University of Minnesota.

2 Present address: Department of Clinical Pathology, Walter Reed General Hospital, Washington, D. C. 20012.

3 Present address: University of Dublin, School of Pathology, Dublin, Ireland.

4 To whom requests for reprints should be addressed, at Department of Laboratory Medicine, University of Minnesota, Mayo 198, Minneapolis, Minn. 55455.

Received 6/28/72. Accepted 8/17/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.